A business in context

TRDA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-14 · 0001689375-26-000057 · Items 7.01,8.01,9.01

  2. 4 · Ownership change

    Report date 2026-09-04 · 0001231919-26-001156

  3. 4 · Ownership change

    Report date 2026-09-04 · 0001231919-26-001155

  4. 4 · Ownership change

    Report date 2026-09-02 · 0001873394-26-000005

  5. 4 · Ownership change

    Report date 2026-09-02 · 0001873392-26-000006

  6. 4 · Ownership change

    Report date 2026-09-02 · 0001725663-26-000007

  7. 4 · Ownership change

    Report date 2026-09-02 · 0001613084-26-000004

  8. 4 · Ownership change

    Report date 2026-09-01 · 0001231919-26-001144

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001231919-26-001143

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001689375-26-000054

  11. 8-K · Current report

    Report date 2026-08-05 · 0001689375-26-000052 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-06-10 · 0001104659-26-072326 · Items 5.02,5.07,9.01

  13. 8-K · Current report

    Report date 2026-05-18 · 0001104659-26-063325 · Items 7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001689375-26-000028

  15. 8-K · Current report

    Report date 2026-05-07 · 0001689375-26-000027 · Items 2.02,7.01,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001689375-26-000021

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001689375-26-000011

  18. 8-K · Current report

    Report date 2026-02-26 · 0001689375-26-000009 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-08 · 0001689375-26-000003 · Items 2.02,7.01,8.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001689375-25-000050

  21. 8-K · Current report

    Report date 2025-11-06 · 0001689375-25-000049 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001689375-25-000043

  23. 8-K · Current report

    Report date 2025-08-06 · 0001689375-25-000041 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-06-11 · 0001104659-25-058536 · Items 5.07

  25. 8-K · Current report

    Report date 2025-05-30 · 0001689375-25-000027 · Items 5.02,7.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001689375-25-000024

  27. 8-K · Current report

    Report date 2025-05-08 · 0001689375-25-000022 · Items 2.02

  28. 8-K · Current report

    Report date 2025-04-29 · 0001104659-25-041204 · Items 2.05

  29. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0001104659-25-039000

  30. 8-K · Current report

    Report date 2025-03-24 · 0001689375-25-000018 · Items 7.01,8.01,9.01

  31. 10-K · Annual report

    Report date 2024-12-31 · 0001689375-25-000011

  32. 8-K · Current report

    Report date 2025-02-27 · 0001689375-25-000009 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-02-24 · 0001689375-25-000004 · Items 7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-02-03 · 0001689375-25-000002 · Items 7.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-01-15 · 0001104659-25-003755 · Items 2.02,8.01,9.01

  36. SC 13G/A · Ownership disclosure

    0000080255-24-001476

  37. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001689375-24-000063

  38. 8-K · Current report

    Report date 2024-11-05 · 0001689375-24-000061 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001689375-24-000047

  40. 8-K · Current report

    Report date 2024-08-13 · 0001689375-24-000045 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 33 transaction rows33SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

37 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-09
2026-09-09
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock28837.07.13
2026-09-09
2026-09-09
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock28837.07.13
2026-09-08
2026-09-09
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock192500.07.41
2026-09-08
2026-09-09
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock192500.07.41
2026-09-04
2026-09-09
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock38500.07.11
2026-09-04
2026-09-09
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock38500.07.11
2026-09-03
2026-09-03
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock32263.07.17
2026-09-03
2026-09-03
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock32263.07.17
2026-09-02
2026-09-03
Sethuraman NatarajanF · Tax / exercise payment
Disposed
Common Stock2079.07.14
2026-09-02
2026-09-03
Dowden Nathan JF · Tax / exercise payment
Disposed
Common Stock2528.07.14
2026-09-02
2026-09-03
WENTWORTH KORY JAMESF · Tax / exercise payment
Disposed
Common Stock1733.07.14
2026-09-02
2026-09-03
Doshi DipalF · Tax / exercise payment
Disposed
Common Stock8724.07.14
2026-09-02
2026-09-03
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock25131.07.19
2026-09-02
2026-09-03
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock25131.07.19
2026-09-01
2026-09-03
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock29088.07.06
2026-09-01
2026-09-03
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock29088.07.06
2026-08-31
2026-08-31
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock44259.06.99
2026-08-31
2026-08-31
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock44259.06.99
2026-08-28
2026-08-31
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock3733.07.01
2026-08-28
2026-08-31
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock3733.07.01
2026-08-27
2026-08-31
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock38922.07.2
2026-08-27
2026-08-31
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock38922.07.2
2026-08-26
2026-08-26
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock14569.07.06
2026-08-26
2026-08-26
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock14569.07.06
2026-08-25
2026-08-26
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock26522.07.54
2026-08-25
2026-08-26
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock26522.07.54
2026-08-24
2026-08-26
EVNIN LUKE; Foley Todd; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P.S · Sale
Disposed
Common Stock21623.07.34
2026-08-24
2026-08-26
MPM BIOVENTURES 2018, L.P.; MPM BioVentures 2018 GP LLC; MPM BioVentures 2018 LLCS · Sale
Disposed
Common Stock21623.07.34
2026-08-10
2026-08-10
PARMAR KUSHS · Sale
Disposed
Common Stock92444.07.0
2026-08-07
2026-08-10
PARMAR KUSHS · Sale
Disposed
Common Stock52317.06.85
2026-08-07
2026-08-10
5AM Opportunities I (GP), LLC; 5AM Opportunities I, L.P.; 5AM Partners V, LLC; 5AM Ventures V, L.P.; ROCKLAGE SCOTT M; Schwab Andrew J.S · Sale
Disposed
Common Stock52317.06.85
2026-08-06
2026-08-10
PARMAR KUSHS · Sale
Disposed
Common Stock10494.07.0
2026-08-06
2026-08-10
5AM Opportunities I (GP), LLC; 5AM Opportunities I, L.P.; 5AM Partners V, LLC; 5AM Ventures V, L.P.; ROCKLAGE SCOTT M; Schwab Andrew J.S · Sale
Disposed
Common Stock10494.07.0
2026-07-31
2026-08-03
PARMAR KUSHS · Sale
Disposed
Common Stock1718.06.85
2026-07-31
2026-08-03
5AM Opportunities I (GP), LLC; 5AM Opportunities I, L.P.; 5AM Partners V, LLC; 5AM Ventures V, L.P.; ROCKLAGE SCOTT M; Schwab Andrew J.S · Sale
Disposed
Common Stock1718.06.85
2026-07-30
2026-08-03
PARMAR KUSHS · Sale
Disposed
Common Stock114756.06.93
2026-07-30
2026-08-03
5AM Opportunities I (GP), LLC; 5AM Opportunities I, L.P.; 5AM Partners V, LLC; 5AM Ventures V, L.P.; ROCKLAGE SCOTT M; Schwab Andrew J.S · Sale
Disposed
Common Stock114756.06.93

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001689375Entrada Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • CycloPorters, Inc. · former SEC name · 2016-11-10 to 2016-11-10

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$210.78M$226.40M
2023-12-31$129.01M$142.65M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗